These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18257752)
1. Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy. Atkinson TJ Obes Rev; 2008 Mar; 9(2):108-20. PubMed ID: 18257752 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine control of food intake. Valassi E; Scacchi M; Cavagnini F Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):158-68. PubMed ID: 18061414 [TBL] [Abstract][Full Text] [Related]
3. Endocrine receptors as targets for new drugs. Altman J Neuroendocrinology; 2006; 83(5-6):282-8. PubMed ID: 16926529 [TBL] [Abstract][Full Text] [Related]
4. Drug strategies for the treatment of obesity. Alemany M; Remesar X; Fernández-López JA IDrugs; 2003 Jun; 6(6):566-72. PubMed ID: 12811679 [TBL] [Abstract][Full Text] [Related]
5. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors. Jensen MD Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496 [TBL] [Abstract][Full Text] [Related]
6. A critical review of the cannabinoid receptor as a drug target for obesity management. Akbas F; Gasteyger C; Sjödin A; Astrup A; Larsen TM Obes Rev; 2009 Jan; 10(1):58-67. PubMed ID: 18721231 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of (ant)-agonists that alter appetite and adiposity. Van der Ploeg LH; Kanatani A; MacNeil D; Ming Fong T; Strack A; Nargund R; Guan XM Prog Brain Res; 2006; 153():107-18. PubMed ID: 16876570 [TBL] [Abstract][Full Text] [Related]
8. Novel therapeutic targets for appetite regulation. Small CJ; Parkinson JR; Bloom SR Curr Opin Investig Drugs; 2005 Apr; 6(4):369-72. PubMed ID: 15898343 [TBL] [Abstract][Full Text] [Related]
9. [Peptides are opening the door for novel treatments of obesity and loss of appetite]. Broberger C; Hökfelt T Lakartidningen; 2002 Dec; 99(49):4982-9. PubMed ID: 12522988 [TBL] [Abstract][Full Text] [Related]
11. Molecular network of obesity: what does it promise for pharmacotherapy? Myslobodsky M Obes Rev; 2008 May; 9(3):236-45. PubMed ID: 18034789 [TBL] [Abstract][Full Text] [Related]
12. Neuropharmacology of human appetite expression. Halford JC; Harrold JA Dev Disabil Res Rev; 2008; 14(2):158-64. PubMed ID: 18646016 [TBL] [Abstract][Full Text] [Related]
13. The obesity pipeline: current strategies in the development of anti-obesity drugs. Cooke D; Bloom S Nat Rev Drug Discov; 2006 Nov; 5(11):919-31. PubMed ID: 17080028 [TBL] [Abstract][Full Text] [Related]
14. Histamine and the regulation of body weight. Jørgensen EA; Knigge U; Warberg J; Kjaer A Neuroendocrinology; 2007; 86(3):210-4. PubMed ID: 17848791 [TBL] [Abstract][Full Text] [Related]
16. Prospects for an anti-ghrelin vaccine to treat obesity. Carlson MJ; Cummings DE Mol Interv; 2006 Oct; 6(5):249-52. PubMed ID: 17035664 [TBL] [Abstract][Full Text] [Related]
17. Regulation of appetite to treat obesity. Kim GW; Lin JE; Valentino MA; Colon-Gonzalez F; Waldman SA Expert Rev Clin Pharmacol; 2011 Mar; 4(2):243-59. PubMed ID: 21666781 [TBL] [Abstract][Full Text] [Related]
18. Regulation of food intake by gastrointestinal hormones. Baynes KC; Dhillo WS; Bloom SR Curr Opin Gastroenterol; 2006 Nov; 22(6):626-31. PubMed ID: 17053440 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine and physiological regulation of intake with particular reference to domesticated ruminant animals. Roche JR; Blache D; Kay JK; Miller DR; Sheahan AJ; Miller DW Nutr Res Rev; 2008 Dec; 21(2):207-34. PubMed ID: 19087372 [TBL] [Abstract][Full Text] [Related]
20. Drug-induced hyperphagia: what can we learn from psychiatric medications? Jensen GL JPEN J Parenter Enteral Nutr; 2008; 32(5):578-81. PubMed ID: 18753398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]